Gasco MR - Search Results

1

Scale-up of the preparation process of solid lipid nanospheres. Part I.

Marengo E, Cavalli R, Caputo O, Rodriguez L, Gasco MR. Marengo E, et al. Among authors: gasco mr. Int J Pharm. 2000 Sep 15;205(1-2):3-13. doi: 10.1016/s0378-5173(00)00471-3. Int J Pharm. 2000. PMID: 11000537

2

Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin.

Cavalli R, Gasco MR, Chetoni P, Burgalassi S, Saettone MF. Cavalli R, et al. Among authors: gasco mr. Int J Pharm. 2002 May 15;238(1-2):241-5. doi: 10.1016/s0378-5173(02)00080-7. Int J Pharm. 2002. PMID: 11996827

3

Incorporation of cyclosporin A in solid lipid nanoparticles (SLN).

Ugazio E, Cavalli R, Gasco MR. Ugazio E, et al. Among authors: gasco mr. Int J Pharm. 2002 Jul 25;241(2):341-4. doi: 10.1016/s0378-5173(02)00268-5. Int J Pharm. 2002. PMID: 12100861

4

Scale-up and optimization of an evaporative drying process applied to aqueous dispersions of solid lipid nanoparticles.

Marengo E, Cavalli R, Rovero G, Gasco MR. Marengo E, et al. Among authors: gasco mr. Pharm Dev Technol. 2003 Aug;8(3):299-309. doi: 10.1081/pdt-120022158. Pharm Dev Technol. 2003. PMID: 12901695

5

Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with beta-cyclodextrins.

Cavalli R, Peira E, Caputo O, Gasco MR. Cavalli R, et al. Among authors: gasco mr. Int J Pharm. 1999 May 10;182(1):59-69. doi: 10.1016/s0378-5173(99)00066-6. Int J Pharm. 1999. PMID: 10332075

6

Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN).

Zara GP, Cavalli R, Fundarò A, Bargoni A, Caputo O, Gasco MR. Zara GP, et al. Among authors: gasco mr. Pharmacol Res. 1999 Sep;40(3):281-6. doi: 10.1006/phrs.1999.0509. Pharmacol Res. 1999. PMID: 10479474

7

Preparation and characterization of solid lipid nanospheres containing paclitaxel.

Cavalli R, Caputo O, Gasco MR. Cavalli R, et al. Among authors: gasco mr. Eur J Pharm Sci. 2000;10(4):305-9. doi: 10.1016/s0928-0987(00)00081-6. Eur J Pharm Sci. 2000. PMID: 10838020

8

Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel.

Miglietta A, Cavalli R, Bocca C, Gabriel L, Gasco MR. Miglietta A, et al. Among authors: gasco mr. Int J Pharm. 2000 Dec 4;210(1-2):61-7. doi: 10.1016/s0378-5173(00)00562-7. Int J Pharm. 2000. PMID: 11163988

9

Timolol in lipospheres.

Gasco MR, Cavalli R, Carlotti ME. Gasco MR, et al. Pharmazie. 1992 Feb;47(2):119-21. Pharmazie. 1992. PMID: 1635918

10

Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats.

Bargoni A, Cavalli R, Caputo O, Fundarò A, Gasco MR, Zara GP. Bargoni A, et al. Among authors: gasco mr. Pharm Res. 1998 May;15(5):745-50. doi: 10.1023/a:1011975120776. Pharm Res. 1998. PMID: 9619784

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters